Ethambutol-Induced Renal Injury Mechanism

Pharmacokinetic and Risk Factors

The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, suggests that pre-existing renal insufficiency significantly increases the risk of ethambutol nephrotoxicity 1, 3
Higher doses (>30 mg/kg/day) of ethambutol increase the risk of toxicity, including renal effects, according to the American Thoracic Society, as published in the American Journal of Respiratory and Critical Care Medicine 3

The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, recommends that ethambutol dosage must be adjusted in patients with renal insufficiency to prevent accumulation and toxicity 1, 3
For patients with end-stage renal disease, the American Thoracic Society, as published in the American Journal of Respiratory and Critical Care Medicine, suggests that ethambutol should be administered at a dose of 15-20 mg/kg three times a week after dialysis 1, 3
Regular monitoring of renal function is essential during ethambutol therapy, especially in patients with pre-existing renal impairment, as recommended by the American Thoracic Society, and published in the American Journal of Respiratory and Critical Care Medicine 3